314 related articles for article (PubMed ID: 29746779)
1. Energy Metabolism Drugs Block Triple Negative Breast Metastatic Cancer Cell Phenotype.
Pacheco-Velázquez SC; Robledo-Cadena DX; Hernández-Reséndiz I; Gallardo-Pérez JC; Moreno-Sánchez R; Rodríguez-Enríquez S
Mol Pharm; 2018 Jun; 15(6):2151-2164. PubMed ID: 29746779
[TBL] [Abstract][Full Text] [Related]
2. Anti-mitochondrial therapy in human breast cancer multi-cellular spheroids.
Mandujano-Tinoco EA; Gallardo-Pérez JC; Marín-Hernández A; Moreno-Sánchez R; Rodríguez-Enríquez S
Biochim Biophys Acta; 2013 Mar; 1833(3):541-51. PubMed ID: 23195224
[TBL] [Abstract][Full Text] [Related]
3. Hypoglycemia Enhances Epithelial-Mesenchymal Transition and Invasiveness, and Restrains the Warburg Phenotype, in Hypoxic HeLa Cell Cultures and Microspheroids.
Marín-Hernández Á; Gallardo-Pérez JC; Hernández-Reséndiz I; Del Mazo-Monsalvo I; Robledo-Cadena DX; Moreno-Sánchez R; Rodríguez-Enríquez S
J Cell Physiol; 2017 Jun; 232(6):1346-1359. PubMed ID: 27661776
[TBL] [Abstract][Full Text] [Related]
4. Anacardic Acid, Salicylic Acid, and Oleic Acid Differentially Alter Cellular Bioenergetic Function in Breast Cancer Cells.
Radde BN; Alizadeh-Rad N; Price SM; Schultz DJ; Klinge CM
J Cell Biochem; 2016 Nov; 117(11):2521-32. PubMed ID: 26990649
[TBL] [Abstract][Full Text] [Related]
5. Dual regulation of energy metabolism by p53 in human cervix and breast cancer cells.
Hernández-Reséndiz I; Román-Rosales A; García-Villa E; López-Macay A; Pineda E; Saavedra E; Gallardo-Pérez JC; Alvarez-Ríos E; Gariglio P; Moreno-Sánchez R; Rodríguez-Enríquez S
Biochim Biophys Acta; 2015 Dec; 1853(12):3266-78. PubMed ID: 26434996
[TBL] [Abstract][Full Text] [Related]
6. Resveratrol inhibits cancer cell proliferation by impairing oxidative phosphorylation and inducing oxidative stress.
Rodríguez-Enríquez S; Pacheco-Velázquez SC; Marín-Hernández Á; Gallardo-Pérez JC; Robledo-Cadena DX; Hernández-Reséndiz I; García-García JD; Belmont-Díaz J; López-Marure R; Hernández-Esquivel L; Sánchez-Thomas R; Moreno-Sánchez R
Toxicol Appl Pharmacol; 2019 May; 370():65-77. PubMed ID: 30878505
[TBL] [Abstract][Full Text] [Related]
7. Celecoxib and Dimethylcelecoxib Block Oxidative Phosphorylation, Epithelial-Mesenchymal Transition and Invasiveness in Breast Cancer Stem Cells.
Gallardo-Pérez JC; Adán-Ladrón de Guevara A; García-Amezcua MA; Robledo-Cadena DX; Pacheco-Velázquez SC; Belmont-Díaz JA; Vargas-Navarro JL; Moreno-Sánchez R; Rodríguez-Enríquez S
Curr Med Chem; 2022; 29(15):2719-2735. PubMed ID: 34636290
[TBL] [Abstract][Full Text] [Related]
8. Casiopeina II-gly and bromo-pyruvate inhibition of tumor hexokinase, glycolysis, and oxidative phosphorylation.
Marín-Hernández A; Gallardo-Pérez JC; López-Ramírez SY; García-García JD; Rodríguez-Zavala JS; Ruiz-Ramírez L; Gracia-Mora I; Zentella-Dehesa A; Sosa-Garrocho M; Macías-Silva M; Moreno-Sánchez R; Rodríguez-Enríquez S
Arch Toxicol; 2012 May; 86(5):753-66. PubMed ID: 22349057
[TBL] [Abstract][Full Text] [Related]
9. Effect of metformin on estrogen and progesterone receptor-positive (MCF-7) and triple-negative (MDA-MB-231) breast cancer cells.
Amaral I; Silva C; Correia-Branco A; Martel F
Biomed Pharmacother; 2018 Jun; 102():94-101. PubMed ID: 29550639
[TBL] [Abstract][Full Text] [Related]
10. The α-tocopherol derivative ESeroS-GS induces cell death and inhibits cell motility of breast cancer cells through the regulation of energy metabolism.
Zhao L; Zhao X; Zhao K; Wei P; Fang Y; Zhang F; Zhang B; Ogata K; Mori A; Wei T
Eur J Pharmacol; 2014 Dec; 745():98-107. PubMed ID: 25446928
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of the Warburg effect with a natural compound reveals a novel measurement for determining the metastatic potential of breast cancers.
Arora R; Schmitt D; Karanam B; Tan M; Yates C; Dean-Colomb W
Oncotarget; 2015 Jan; 6(2):662-78. PubMed ID: 25575825
[TBL] [Abstract][Full Text] [Related]
12. Effects of sorafenib on energy metabolism in breast cancer cells: role of AMPK-mTORC1 signaling.
Fumarola C; Caffarra C; La Monica S; Galetti M; Alfieri RR; Cavazzoni A; Galvani E; Generali D; Petronini PG; Bonelli MA
Breast Cancer Res Treat; 2013 Aug; 141(1):67-78. PubMed ID: 23963659
[TBL] [Abstract][Full Text] [Related]
13. Assessment of the low inhibitory specificity of oxamate, aminooxyacetate and dichloroacetate on cancer energy metabolism.
Moreno-Sánchez R; Marín-Hernández Á; Del Mazo-Monsalvo I; Saavedra E; Rodríguez-Enríquez S
Biochim Biophys Acta Gen Subj; 2017 Jan; 1861(1 Pt A):3221-3236. PubMed ID: 27538376
[TBL] [Abstract][Full Text] [Related]
14. Control of cellular proliferation by modulation of oxidative phosphorylation in human and rodent fast-growing tumor cells.
Rodríguez-Enríquez S; Vital-González PA; Flores-Rodríguez FL; Marín-Hernández A; Ruiz-Azuara L; Moreno-Sánchez R
Toxicol Appl Pharmacol; 2006 Sep; 215(2):208-17. PubMed ID: 16580038
[TBL] [Abstract][Full Text] [Related]
15. FR58P1a; a new uncoupler of OXPHOS that inhibits migration in triple-negative breast cancer cells via Sirt1/AMPK/β1-integrin pathway.
Urra FA; Muñoz F; Córdova-Delgado M; Ramírez MP; Peña-Ahumada B; Rios M; Cruz P; Ahumada-Castro U; Bustos G; Silva-Pavez E; Pulgar R; Morales D; Varela D; Millas-Vargas JP; Retamal E; Ramírez-Rodríguez O; Pessoa-Mahana H; Pavani M; Ferreira J; Cárdenas C; Araya-Maturana R
Sci Rep; 2018 Sep; 8(1):13190. PubMed ID: 30181620
[TBL] [Abstract][Full Text] [Related]
16. KR-33028, a potent inhibitor of the Na
Amith SR; Wilkinson JM; Fliegel L
Biochem Pharmacol; 2016 Oct; 118():31-39. PubMed ID: 27521504
[TBL] [Abstract][Full Text] [Related]
17. Marizomib suppresses triple-negative breast cancer via proteasome and oxidative phosphorylation inhibition.
Raninga PV; Lee A; Sinha D; Dong LF; Datta KK; Lu X; Kalita-de Croft P; Dutt M; Hill M; Pouliot N; Gowda H; Kalimutho M; Neuzil J; Khanna KK
Theranostics; 2020; 10(12):5259-5275. PubMed ID: 32373211
[No Abstract] [Full Text] [Related]
18. Oxidative phosphorylation is impaired by prolonged hypoxia in breast and possibly in cervix carcinoma.
Rodríguez-Enríquez S; Carreño-Fuentes L; Gallardo-Pérez JC; Saavedra E; Quezada H; Vega A; Marín-Hernández A; Olín-Sandoval V; Torres-Márquez ME; Moreno-Sánchez R
Int J Biochem Cell Biol; 2010 Oct; 42(10):1744-51. PubMed ID: 20654728
[TBL] [Abstract][Full Text] [Related]
19. Caffeine and Cisplatin Effectively Targets the Metabolism of a Triple-Negative Breast Cancer Cell Line Assessed via Phasor-FLIM.
Pascua SM; McGahey GE; Ma N; Wang JJ; Digman MA
Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32244616
[TBL] [Abstract][Full Text] [Related]
20. Proteomic Analysis Reveals That an Extract of the Plant Lippia origanoides Suppresses Mitochondrial Metabolism in Triple-Negative Breast Cancer Cells.
Raman V; Aryal UK; Hedrick V; Ferreira RM; Fuentes Lorenzo JL; Stashenko EE; Levy M; Levy MM; Camarillo IG
J Proteome Res; 2018 Oct; 17(10):3370-3383. PubMed ID: 30185032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]